Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS

PHASE4CompletedINTERVENTIONAL
Enrollment

377

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Rhinitis, Allergic, Perennial
Interventions
DRUG

FPNS

fluticasone propionate nasal spray

DRUG

FFNS

fluticasone furoate nasal spray

DRUG

placebo FPNS

placebo nasal spray matching fluticasone propionate nasal spray

DRUG

placebo FFNS

placebo nasal spray matching fluticasone furoate nasal spray

Trial Locations (24)

8724

GSK Investigational Site, Brick

14618

GSK Investigational Site, Rochester

21236

GSK Investigational Site, Baltimore

27607

GSK Investigational Site, Raleigh

29407

GSK Investigational Site, Charleston

29414

GSK Investigational Site, Charleston

29464

GSK Investigational Site, Mt. Pleasant

33176

GSK Investigational Site, Miami

37601

GSK Investigational Site, Johnson City

39202

GSK Investigational Site, Jackson

75110

GSK Investigational Site, Corsicana

77070

GSK Investigational Site, Houston

78028

GSK Investigational Site, Kerrville

78229

GSK Investigational Site, San Antonio

79902

GSK Investigational Site, El Paso

85251

GSK Investigational Site, Scottsdale

90808

GSK Investigational Site, Long Beach

92647

GSK Investigational Site, Huntington Beach

92691

GSK Investigational Site, Mission Viejo

92868

GSK Investigational Site, Orange

93720

GSK Investigational Site, Fresno

01845

GSK Investigational Site, North Andover

08558

GSK Investigational Site, Skillman

05403

GSK Investigational Site, South Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00539006 - Comparator Study Evaluating Patient Preference Of FFNS vs. FPNS | Biotech Hunter | Biotech Hunter